Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options
Abstract
Does treatment with sofosbuvir for Hepatitis C genotype 2 or 3 patients for whom peginterferon and ribavirin treatment was not an option lead to a sustained virologic response at 12 week weeks after therapy?Affiliation
Medical College of GeorgiaDescription
Critically appraised topic completed as an assignment in Essentials of Clinical Medicine IISeries/Report no.
Spring2016